Palmaz Scientific, Inc.: Series A $3M

Posted in I - Series A, Q - 2Q10, R - SOUTH WEST, X - Biomaterial, XX - TX

Palmaz Scientific (Dallas, TX) a development-stage nano-biomaterials company focused on a vapor deposition process to increase the reliability of implantable prosthetic devices, closed a $3M Series A financing. Participants include Texas Emerging Technology Fund.

BioCeramic Therapeutics, Ltd.: Series B $1.9M

Posted in I - Series B, Q - 4Q09, R - INTERNATIONAL, X - Biomaterial

BioCeramic Therapeutics (United Kingdom) a development-stage provider of bioactive materials for orthopaedic and dental applications, closed a $1.9M Series B financing. Participants include Imperial Innovations, Longbow Capital Partners, Comvest and Esmee Fairbairn Foundation.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

BioCeramic Therapeutics, Ltd.: Series B $1.9M

Posted in I - Series B, Q - 4Q09, R - INTERNATIONAL, X - Biomaterial

BioCeramic Therapeutics (United Kingdom) a development-stage provider of bioactive materials for orthopaedic and dental applications, closed a $1.9M Series B financing. Participants include Imperial Innovations, Longbow Capital Partners, Comvest and Esmee Fairbairn Foundation.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

LifeBond, Ltd.: Series B $8M

Posted in I - Series B, Q - 2Q09, R - INTERNATIONAL, X - Biomaterial, X - Hemostasis, X - Wound Healing

LifeBond (Israel) a commercial-stage developer of wound-closure and hemostasis biomaterials, closed a $8M Series B financing. Participants include Pitango Venture Capital, GlenRock Israel and The Zitelman Group.

Semprus BioSciences Corp.: Series A $8M

Posted in I - Series A, Q - 4Q08, R - NORTH EAST, X - Antiinfective, X - Biomaterial, XX - MA

Semprus BioSciences (Cambridge, MA) an early-stage biomaterial surface coating company closed a $8M Series A financing. Participants include 5AM Ventures and Panagea Ventures.

Healionics Corp.: Series B $2.6M

Posted in I - Series A, Q - 4Q08, R - NORTH WEST, X - Biomaterial, XX - WA

Healionics (Redmond, WA) an early-stage biomaterial surface coating and tissue regeneration company closed a $2.6M Series B financing. Participants include Bellingham Angels, Alliance of Angels, Keiretsu, Tacoma Angel Network and Zino Society.

Interface Biologics, Inc.: Series C $5M

Posted in I - Series C, Q - 4Q08, R - INTERNATIONAL, X - Biomaterial

Interface Biologics (Canada) an early-stage developer of therapeutic biomaterials for use in implantable medical devices closed a $5M Series C financing. Participants include Covington Capital, VG Partners and BDC Capital.

to top of page...